Real-time enrollment status for this early detection of cancer clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 9:00 PM UTC
| NCT Number | NCT06638554 |
| Recruiting Status | Recruiting |
| Condition | Early Detection of Cancer |
| Phase | NA |
| Target Enrollment | 6,000 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | May 29, 2026 (May 29, 2026) |
As of July 21, 2026: Clinical trial NCT06638554 is currently recruiting participants. This na study for early detection of cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06638554 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06638554 was last updated May 29, 2026 (May 29, 2026). HelloStudys verifies this status automatically.